Proportion and impact of low positive versus negative estrogen/progesterone receptor status on survival outcomes in HER2-negative breast cancer
Purpose Estrogen receptor low-positive breast cancer (ER-low) is a new entity introduced by the updated American Society of Clinical Oncology/College of American Pathologists guideline. In such tumors ER is expressed in 1–10% of tumor cells. There is limited data available about the biological behavior of this group. This study aims to assess the proportion of ER-low positive breast cancer in a single institute and compare such group with triple negative one as regard clinicopathologic features and survival. Methods This is a retrospective study that included 103 patients diagnosed and treated as breast cancer at National Cancer Institute, Cairo University Cases were categorized according to their hormone receptor status into low ER-positive group (ER/PR expression ≤ 10%) and triple negative group. Tumor characteristics, type of treatment, OS and DFS were evaluated among both groups. Results Triple negative and ER-low positive cases were 79 (76.7%) and 24 (23.3%), respectively. Demographic, clinic-pathologic and treatment characteristics were comparable between both groups. Triple negative group shows higher histologic grade than ER-low positive group (p value = 0.002). According to survival status, there is no significant difference in OS and DFS between triple negative and low ER positive group. In 58 patients receiving neoadjuvant chemotherapy (13 ER-low versus 45 triple negative cases), triple negative group showed higher complete pathologic response when compared to ER-low positive group, despite this difference is not statistically significant (12.7% versus 4.2% respectively, p = 0.513). Conclusion ER-low positive group has the same clinical behavior as triple negative breast cancer.
Authors
- Marwa A Ahmed (ORCID: https://orcid.org/0009-0001-6614-7828)
- Nancy H Amin
- Mohamed Yousri Ahmed
- Mostafa A Hussein
Institutions
- Cairo University (EG)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11543768/v1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- preprint